Dilpacimab, CAS 1791420-09-1

Product Description: Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways.. Dilpacimab can be used in research of cancer[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Gordon MS, et, al. Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors. Mol Cancer Ther. 2021 Oct;20(10):1988-1995.

CAS Number: 1791420-09-1

Molecular Weight: N/A

Compound Purity: 96.88

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: VEGFR

• SKU: MEXHY-P99852-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99852-1
• Package Unit: 1 mg
• Quantity Unit: STK
• Conjugate: Unconjugated